Patients with primary hand osteoarthritis should not be prescribed hydroxychloroquine, study suggests

The results of an interventional trial showed that use of the disease-modifying anti-rheumatic drug hydroxychloroquine for 24 weeks did not diminish mild-moderate pain from primary hand osteoarthritis.